Mankind Pharma transfers OTC biz to subsidiary
Slump sale to be effective on or before October 1, 2024
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
El Toro Finserve LLP releases 2024 – Healthcare Investment Manifesto for India
Report builds on consumer sentiments and emerging trends to bet on the ideas that will become mainstream or even a unicorn by 2029
Newly-announced elevated corridor to boost Genome Valley’s ecosystem and economy
Pushes the accelerator for three-phased Genome Valley: Rx Propellant
Harness data to unleash power of Indian pharma industry
Saransh Chaudhary, President, Global Critical Care Division, Venus Remedies, and CEO, Venus Medicine Research Centre details how…
Eyestem to start human trials for its dry AMD treatment
Eyestem’s Eyecyte RPE therapy aims to replace lost or damaged retinal pigment epithelium (RPE) cells
Bharat Biotech, Bilthoven Biologicals B.V. partner to produce and supply oral polio vaccines
BBIL will procure drug substances for the production of oral polio vaccines to be supplied within India and globally
GS Krishnan re-elected ABLE President for 2024 -2026
Krishnan will head a 14-member governing body that was elected for a two -year term during the recently held elections
Alembic Pharma appoints Manish Kejriwal as Independent Director
Kejriwal brings over 30 years of experience in private equity investments and is currently the founder and Managing Partner of…
WHO INN approves ‘Usnoflast’ as recommended name for ZYIL1 from Zydus
Usnoflast (ZYIL1) is a novel oral small molecule NLRP3 inhibitor discovered at Zydus. Studies have demonstrated that ZYIL1 is…
Bora Pharmaceuticals acquires Upsher-Smith
The acquisition expands Taiwan-based Bora’s North American footprint with its first US manufacturing site
A step towards global harmonisation of GMP inspection protocols
Linking purchase of electoral bonds to inaction on questionable quality standards is yet another warning to all pharma companies…
Active cooperation among APAC pharma companies gaining traction: GlobalData
According to GlobalData’s Pharmaceutical Intelligence Center, from 2019 to 2023, 673 deals (strategic alliances) occurred among…
Jubilant Ingrevia commissions new facility for Diketene and derivatives
The newly commissioned facility adds additional capacity of ~2,000 TPA to produce high-value esters
New study reveals potential link between delirium and dementia
The study shows that patients who had at least one episode of delirium while in hospital went on to develop dementia at triple the…
Caplin Steriles gets USFDA approval for Ketorolac Tromethamine Ophthalmic Solution
It is a nonsteroidal, anti-inflammatory indicated for the treatment of inflammation following cataract surgery and for the…
The emergence of india’s life science powerhouses: A deep dive
Vishal Goel, Managing Director, RX Propellant highlights that by fostering collaboration, nurturing talent, and addressing key…
Credit profile of Indian pharma cos to remain healthy in FY2025 despite moderation in revenue…
Revenue growth to moderate to 8-10 per cent in FY2025, post a healthy 13-14 per cent YoY expansion in FY2024
Veeda Clinical Research acquires Heads, a European CRO
Veeda expands its reach to major geographies and adds capabilities of late-stage clinical trial execution with strong focus on…
AstraZeneca India gets dual CDSCO approval for Trastuzumab deruxtecan
Additional indications for treatment of HER2 low breast cancer and HER2 positive gastric / gastro-oesophageal cancer
Sanofi signs distribution pact with Cipla for CNS portfolio in India
Cipla will be responsible for the distribution of Sanofi India’s six CNS brands including Frisium